Recall record at a glance
| Official record | F-0871-2020 |
|---|---|
| Category | Food Recalls |
| Classification | Class I |
| FDA record status | Terminated |
| Recalling firm | New Capstone, Inc. |
| Report date | Apr 8, 2020 |
| Recall initiation date | Mar 2, 2020 |
| Quantity | 3,235/527g pouches + 3,497/27g packets |
| Location | Mooresville, NC, United States |
Official product description
ReStructure VANILLA PROTEIN POWDER NET WT. 527G POUCH & 27G SINGLE PACKET Other Ingredients: Non-GMO rBGH-Free Whey Protein Concentrate, Rice Bran and Germ*** Manufactured for & distributed by: New Capstone, Inc. 125 Trade Court, Suite F44, Mooresville, NC 28117 1-888-577-3703 UPC 8 67780 00020 6
Why the product was recalled
The firm was notified that the labeling does not include the word milk on the ingredient statement
Distribution information
Product was distributed Nationwide
How to read the classification
FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Letter.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.